Global Mucopolysaccharidosis (MPS) Treatment Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 181020
  • calendar_today Published On: Jul, 2019
  • file_copy Pages: 117
  • list Pharmaceuticals and Healthcare

Mucopolysaccharidoses are a group of metabolic disorders caused by the absence or malfunctioning of lysosomal enzymes needed to break down molecules called glycosaminoglycans. These long chains of sugar carbohydrates occur within the cells that help build bone, cartilage, tendons, corneas, skin and connective tissue. Glycosaminoglycans (formerly called mucopolysaccharides) are also found in the fluids that lubricate joints.

Scope of the Report:

The global Mucopolysaccharidosis (MPS) Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mucopolysaccharidosis (MPS) Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.

This report studies the Mucopolysaccharidosis (MPS) Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mucopolysaccharidosis (MPS) Treatment market by product type and applications/end industries.

Market Segment by Companies, this report covers

Sanofi

Shire (Takeda)

BioMarin Pharmaceutical

Esteve

REGENXBIO Inc

Sangamo Therapeutics

Ultragenyx Pharmaceutical

Abeona Therapeutics

ArmaGen

Eloxx Pharmaceuticals

Inventiva

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Stem Cell Therapies

Enzyme Replacement Therapies

Market Segment by Applications, can be divided into

Hospitals

Clinics

Homecare

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Mucopolysaccharidosis (MPS) Treatment Market Overview

1.1 Product Overview and Scope of Mucopolysaccharidosis (MPS) Treatment

1.2 Classification of Mucopolysaccharidosis (MPS) Treatment by Types

1.2.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue Comparison by Types (2019-2024)

1.2.2 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Types in 2018

1.2.3 Stem Cell Therapies

1.2.4 Enzyme Replacement Therapies

1.3 Global Mucopolysaccharidosis (MPS) Treatment Market by Application

1.3.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size and Market Share Comparison by Applications (2014-2024)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Homecare

1.4 Global Mucopolysaccharidosis (MPS) Treatment Market by Regions

1.4.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size (Million USD) Comparison by Regions (2014-2024)

1.4.1 North America (USA, Canada and Mexico) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)

1.4.4 South America (Brazil, Argentina, Colombia) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mucopolysaccharidosis (MPS) Treatment Status and Prospect (2014-2024)

1.5 Global Market Size of Mucopolysaccharidosis (MPS) Treatment (2014-2024)

2 Manufacturers Profiles

2.1 Sanofi

2.1.1 Business Overview

2.1.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Sanofi Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.2 Shire (Takeda)

2.2.1 Business Overview

2.2.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Shire (Takeda) Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.3 BioMarin Pharmaceutical

2.3.1 Business Overview

2.3.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 BioMarin Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.4 Esteve

2.4.1 Business Overview

2.4.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Esteve Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.5 REGENXBIO Inc

2.5.1 Business Overview

2.5.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 REGENXBIO Inc Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.6 Sangamo Therapeutics

2.6.1 Business Overview

2.6.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sangamo Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.7 Ultragenyx Pharmaceutical

2.7.1 Business Overview

2.7.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Ultragenyx Pharmaceutical Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.8 Abeona Therapeutics

2.8.1 Business Overview

2.8.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Abeona Therapeutics Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.9 ArmaGen

2.9.1 Business Overview

2.9.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 ArmaGen Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.10 Eloxx Pharmaceuticals

2.10.1 Business Overview

2.10.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Eloxx Pharmaceuticals Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

2.11 Inventiva

2.11.1 Business Overview

2.11.2 Mucopolysaccharidosis (MPS) Treatment Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Inventiva Mucopolysaccharidosis (MPS) Treatment Revenue, Gross Margin and Market Share (2017-2018)

3 Global Mucopolysaccharidosis (MPS) Treatment Market Competition, by Players

3.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue and Share by Players (2014-2019)

3.2 Market Concentration Rate

3.2.1 Top 5 Mucopolysaccharidosis (MPS) Treatment Players Market Share

3.2.2 Top 10 Mucopolysaccharidosis (MPS) Treatment Players Market Share

3.3 Market Competition Trend

4 Global Mucopolysaccharidosis (MPS) Treatment Market Size by Regions

4.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue and Market Share by Regions

4.2 North America Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

4.3 Europe Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

4.4 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

4.5 South America Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

4.6 Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

5 North America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries

5.1 North America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)

5.2 USA Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

5.3 Canada Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

5.4 Mexico Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

6 Europe Mucopolysaccharidosis (MPS) Treatment Revenue by Countries

6.1 Europe Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)

6.2 Germany Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

6.3 UK Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

6.4 France Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

6.5 Russia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

6.6 Italy Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue by Countries

7.1 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)

7.2 China Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

7.3 Japan Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

7.4 Korea Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

7.5 India Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

7.6 Southeast Asia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

8 South America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries

8.1 South America Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)

8.2 Brazil Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

8.3 Argentina Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

8.4 Colombia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Mucopolysaccharidosis (MPS) Treatment by Countries

9.1 Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue by Countries (2014-2019)

9.2 Saudi Arabia Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

9.3 UAE Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

9.4 Egypt Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

9.5 Nigeria Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

9.6 South Africa Mucopolysaccharidosis (MPS) Treatment Revenue and Growth Rate (2014-2019)

10 Global Mucopolysaccharidosis (MPS) Treatment Market Segment by Type

10.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue and Market Share by Type (2014-2019)

10.2 Global Mucopolysaccharidosis (MPS) Treatment Market Forecast by Type (2019-2024)

10.3 Stem Cell Therapies Revenue Growth Rate (2014-2024)

10.4 Enzyme Replacement Therapies Revenue Growth Rate (2014-2024)

11 Global Mucopolysaccharidosis (MPS) Treatment Market Segment by Application

11.1 Global Mucopolysaccharidosis (MPS) Treatment Revenue Market Share by Application (2014-2019)

11.2 Mucopolysaccharidosis (MPS) Treatment Market Forecast by Application (2019-2024)

11.3 Hospitals Revenue Growth (2014-2019)

11.4 Clinics Revenue Growth (2014-2019)

11.5 Homecare Revenue Growth (2014-2019)

12 Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast (2019-2024)

12.1 Global Mucopolysaccharidosis (MPS) Treatment Market Size Forecast (2019-2024)

12.2 Global Mucopolysaccharidosis (MPS) Treatment Market Forecast by Regions (2019-2024)

12.3 North America Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)

12.4 Europe Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)

12.5 Asia-Pacific Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)

12.6 South America Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)

12.7 Middle East and Africa Mucopolysaccharidosis (MPS) Treatment Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Mucopolysaccharidosis (MPS) Treatment Picture

Table Product Specifications of Mucopolysaccharidosis (MPS) Treatment

Table Global Mucopolysaccharidosis (MPS) Treatmen

Please fill the form below, to recieve the report sample


+1